Nahdi Medical Reports SAR 450.90M Net Profit in the Six Months 2026

NAHDI

NAHDI

4164.SA

0.00

On 2026-07-29 08:03:13 (Saudi Time), Nahdi Medical Co. announced its Interim financial results for the six months ended on June 30, 2026.

Element List Current Quarter Similar quarter for previous year %Change Previous Quarter % Change
Sales/Revenue 2,674.3 2,527.6 5.803 2,794.4 -4.297
Gross Profit (Loss) 1,007.6 966 4.306 987.7 2.014
Operational Profit (Loss) 245.9 260.6 -5.64 259.7 -5.313
Net Profit (Loss) Attributable to Shareholders of the Issuer 215.2 238.4 -9.731 235.7 -8.697
Total Comprehensive Income Attributable to Shareholders of the Issuer 234 239.4 -2.255 262.1 -10.721
All figures are in (Millions) Saudi Arabia, Riyals
Element List Current Period Similar period for previous year %Change
Sales/Revenue 5,468.7 5,162.5 5.931
Gross Profit (Loss) 1,995.4 1,909.8 4.482
Operational Profit (Loss) 505.6 530.6 -4.711
Net Profit (Loss) Attributable to Shareholders of the Issuer 450.9 493.6 -8.65
Total Comprehensive Income Attributable to Shareholders of the Issuer 496.2 492.4 0.771
Total Shareholders Equity (after Deducting Minority Equity) 2,511.7 2,688.5 -6.576
Profit (Loss) per Share 3.47 3.8
All figures are in (Millions) Saudi Arabia, Riyals
Element List Amount Percentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value - -
All figures are in (Millions) Saudi Arabia, Riyals

Year-on-Year Performance Drivers

For the six-month period ending 30 June 2026, Nahdi Medical Company's revenue grew 5.931% YoY to SAR 5,468.7 million (vs. SAR 5,162.5 million), driven by a 4.4% increase in the Retail business across Pharma and Front Shop segments, alongside strong growth of 34.6% in Healthcare and 28% in regional expansion businesses. Despite the revenue growth, net profit attributable to shareholders declined 8.65% YoY to SAR 450.9 million (vs. SAR 493.6 million), as higher operating expenses related to strategic growth initiatives, healthcare expansion, and digital capabilities weighed on operating profit, which fell 4.711% to SAR 505.6 million, while gross margin also compressed slightly to 36.5% from 37.0% due to a shift in business mix toward lower-margin segments. Additionally, items below operating profit reflected a net increase in expenses of SAR 17.6 million, further pressuring the bottom line.

Quarter-on-Quarter Performance Drivers

QoQ revenue declined 4.3% to SAR 2,674.3 million from SAR 2,794.4 million in the prior quarter, primarily driven by seasonality as Q1 benefited from a sales uplift associated with the Ramadan season. Net profit fell 8.697% QoQ to SAR 215.2 million from SAR 235.7 million, with no further detailed breakdown provided beyond the revenue-driven decline.

Other Items

Nahdi Medical Co.'s external auditor issued an unmodified conclusion for the interim period ending 30 June 2026, with no additional comments noted in any other matter, conservation, notice, disclaimer of opinion, or adverse opinion paragraphs. No material risks or going concern issues were flagged. Total shareholders' equity (after deducting minority equity) stood at SAR 2,511.7 million as of the current period, compared to SAR 2,688.5 million in the same period of the prior year, a decline of 6.576%. Earnings per share for the current period were SAR 3.47, compared to SAR 3.8 in the same period last year. Certain comparative information has been reclassified to align with the current period presentation ending 30 June 2026. Other Comprehensive Income increased due to a decrease in actuarial expense resulting from a re-assessment of the actuarial estimate for end-of-service indemnity. The Company also noted that, in accordance with its governance, it strictly adheres to Shariah principles in all areas of its business, including banking and investment activities, and as a result, all costs incurred and revenues generated from these activities are Shariah-compliant.

Original announcement:

https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=97047&anCat=1&cs=4164&locale=ar

Attached PDF document link:

https://www.saudiexchange.sa/Resources/fsPdf/17555_2964_2026-07-28_20-28-26_en.pdf

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.